Purchase Order HHSN271201500035A
Award Date
8/14/15
Potential Completion Date
1/31/16
Potential Value
$448K
Funding Federal Agency
National Center for Advancing Translational Sciences
Contracting Federal Agency
National Institute on Drug Abuse
Awardee
Analyticon Discovery, LLC
Ultimate Awardee
Not listed
NAICS Category
325199 - All Other Basic Organic Chemical Manufacturing
PSC Category
6810 - Chemicals
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Potomac, MD 20850, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm-fixed-price purchase order for $149,960.58 awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency, to Analyticon Discovery, LLC, a foreign-owned for-profit organization. The contract is set aside for small businesses and is part of the SMALL MOLECULES FOR NCATS PHARMACOLOGICALLY ACTIVE CHEMICAL TOOLBOX (NPACT) program. The contract is for the delivery of products and services related to small molecules for NCATS' pharmacologically active...
This is a $90,000.00 firm fixed price purchase order awarded by the National Institute on Drug Abuse (NIDA), which is a civilian agency of the U.S. government. The contract, which does not have a set-aside designation, is for the "SMALL MOLECULES FOR NCATS PHARMACOLOGICALLY ACTIVE CHEMICAL TOOLBOX (NPACT)" program and was awarded to DC Chemicals LIMITED, a for-profit limited liability company, on July 9, 2015. The period of performance for this contract ends on November 30, 2015.
This is a $80,400.00 firm fixed price purchase order contract awarded by the National Institute on Drug Abuse (NIDA), a civilian agency, to Axon Medchem B.V., a foreign-owned for-profit organization. The contract is for the Small Molecules for NCATS Pharmacologically Active Chemical Toolbox (NPACT) program, which aims to provide small molecule compounds. The contract has an ultimate completion date of July 25, 2015 and was awarded on April 24, 2015. There was no set-aside designation used for...
<p>The U.S. National Institute on Drug Abuse (NIDA), a civilian federal agency, awarded a $452,500.00 firm fixed-price purchase order contract to Chemroutes Corporation, a foreign-owned for-profit organization, for the Small Molecules for NCATS Pharmacologically Active Chemical Toolbox (NPACT) program. The contract has an ultimate completion date of April 30, 2016 and was awarded on December 23, 2015. This contract was not set aside for any particular business type.</p>
<p>This is a firm fixed-price purchase order awarded by the National Institute on Drug Abuse (NIDA), a civilian agency, to PC SAS, a for-profit organization based in France. The contract, valued at $129,000.00, is for the Small Molecules for NCATS Pharmacologically Active Chemical Toolbox (NPACT) program. The contract does not have a set-aside designation and was awarded on May 15, 2015 with an ultimate completion date of August 31, 2015.</p>
<p>This is a firm fixed-price purchase order contract awarded by the National Institute on Drug Abuse (NIDA), a civilian agency, to Biovision Inc., a small disadvantaged business, on April 24, 2015. The contract is for the Small Molecules for NCATS Pharmacologically Active Chemical Toolbox (NPACT) program, with a ceiling value of $95,640.25 and a completion date of July 25, 2015. The contract does not have a set-aside designation.</p>
The National Institutes of Health (NIH) National Center for Advancing Translational Sciences (NCATS) awarded a $149,600.00 firm-fixed-price purchase order contract to Specs Chemical Services, Inc., a small disadvantaged business, to provide a "Pharmacologically Active Chemical Toolbox (NPACT) Commercial Powder Reformatting to Solutions" service. The contract has an ultimate completion date of March 31, 2016 and was awarded on August 13, 2015. The contract was not set aside for any...
<p>The National Center for Advancing Translational Sciences (NCATS), a civilian agency, awarded a $35,000.00 firm fixed price purchase order contract to Editco Bio Inc., a self-certified small disadvantaged business. The contract, with an ultimate completion date of December 17, 2024, is for the product SYNTHEGO:1293873 [24-007185]. The contract does not have a set-aside designation.</p>
<p>The U.S. Federal Agency, Office of Logistics and Acquisition Operations, awarded a Firm Fixed Price Purchase Order contract to 3Xper Innoventure LTD, a foreign-owned for-profit manufacturing organization, to MANUFACTURE THE SMALL MOLECULES TO INCREASE THE TRANSLATIONAL POTENTIAL. The contract has a ceiling value of $24,200.00 and a performance period ending on December 8, 2025. The contract was awarded on December 9, 2024 and does not have a set-aside designation.</p>
This federal contract award, with the ID HHSN271201500620P, was issued by the National Institute on Drug Abuse (NIDA), a civilian agency within the U.S. government. The contract, with a ceiling value of $148,905.00, was awarded to Chembridge Corp, a for-profit organization based in San Diego, California. The contract is for the Small Molecules for NCATS Pharmacologically Active Chemical Toolbox (NPACT) program, which is a purchase order with a firm fixed price. The contract does not have a...